Literature DB >> 8217587

Long-term survival after pancreatic adenocarcinoma--often a misdiagnosis?

K A Alanen1, H Joensuu.   

Abstract

Prognosis of adenocarcinoma of the pancreas has remained poor, but a few patients are reported to live 5 years or longer after the diagnosis. Using the data of the Finnish Cancer Registry, we could identify only 78 patients (1.3%) who had survived for longer than 5 years after the diagnosis of pancreatic cancer among 5,837 patients diagnosed in Finland in 1975-1984. However, in 33 of the 78 cases a histological diagnosis of pancreatic cancer had never been made, and the majority of the remaining 45 patients turned out not to have pancreatic adenocarcinoma after a review. The results suggest that the majority of patients with long-term survival following the diagnosis of pancreatic cancer have never had pancreatic adenocarcinoma. Taking a biopsy from a suspected pancreatic neoplasm and careful histological evaluation may prohibit misdiagnosis of this highly lethal disease.

Entities:  

Mesh:

Year:  1993        PMID: 8217587      PMCID: PMC1968742          DOI: 10.1038/bjc.1993.469

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

Review 1.  Cancer of the pancreas.

Authors:  D C Carter
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

2.  Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases.

Authors:  J Compagno; J E Oertel
Journal:  Am J Clin Pathol       Date:  1978-06       Impact factor: 2.493

Review 3.  Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct.

Authors:  F Michelassi; F Erroi; P J Dawson; A Pietrabissa; S Noda; M Handcock; G E Block
Journal:  Ann Surg       Date:  1989-10       Impact factor: 12.969

4.  Results of pancreatoduodenectomy for carcinoma of the head of the pancreas.

Authors:  M I Kairaluoma; M Ståhlberg; H Kiviniemi; K Haukipuro
Journal:  Hepatogastroenterology       Date:  1989-12

Review 5.  Classification and staging of pancreatic nonendocrine tumors.

Authors:  G Klöppel; B Maillet
Journal:  Radiol Clin North Am       Date:  1989-01       Impact factor: 2.303

6.  Carcinoma of the pancreas and periampullary region.

Authors:  J F Forrest; W P Longmire
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969

7.  Pancreaticoduodenectomy. University experience and resident education.

Authors:  R J Doerr; I Yildiz; L M Flint
Journal:  Arch Surg       Date:  1990-04

8.  Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases.

Authors:  T Morohoshi; G Held; G Klöppel
Journal:  Histopathology       Date:  1983-09       Impact factor: 5.087

Review 9.  Pancreatic cystic neoplasms.

Authors:  D Mathieu; B Guigui; P J Valette; T H Dao; J N Bruneton; J M Bruel; J Pringot; N Vasile
Journal:  Radiol Clin North Am       Date:  1989-01       Impact factor: 2.303

10.  Pancreatic cystadenoma. A clinicopathologic study of 45 cases.

Authors:  D J Hodgkinson; W H ReMine; L H Weiland
Journal:  Arch Surg       Date:  1978-04
View more
  8 in total

1.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 2.  Pancreatic cancer: any prospects for prevention?

Authors:  A R Hart
Journal:  Postgrad Med J       Date:  1999-09       Impact factor: 2.401

3.  Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group.

Authors:  M Porta; S Costafreda; N Malats; L Guarner; M Soler; J M Gubern; E García-Olivares; M Andreu; A Salas; J M Corominas; J Alguacil; A Carrato; J Rifà; F X Real
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

4.  Difficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitis.

Authors:  Ting-Kai Leung; Chi-Ming Lee; Fong-Chieh Wang; Hsin-Chi Chen; Hung-Jung Wang
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

Review 5.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

6.  Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Authors:  M M Zalupski; A F Shields; P A Philip; M Kraut; P LoRusso; L K Heilbrun; V Vaitkevicius
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

7.  Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression.

Authors:  C M Barton; N R Lemoine
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

8.  Identification of an N staging system that predicts oncologic outcome in resected left-sided pancreatic cancer.

Authors:  Sung Hyun Kim; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.